Immune Pharmaceuticals Files New Patent Application for Ceplene...

2016-02-10T10:53:09-08:00

NEW YORK, Feb. 10, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company, announced today that it has filed a patent application directed to the treatment ...